| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | MARVELD1 |
| Uniprot No | Q9BSK0 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-173aa |
| 活性数据 | MLPPPPRQPPPQARAARGAVRLQRPFLRSPLGVLRLLQLLAGAAFWITIATSKYQGPVHFALFVSVLFWLLTLGLYFLTLLGKHELVPVLGSRWLMVNVAHDVLAAALYGAATGIMSDQMQRHSYCNLKDYPLPCAYHAFLAAAVCGGVCHGLYLLSALYGCGRRCQGKQEVA |
| 分子量 | 45.3 kDa |
| 蛋白标签 | GST-tag at N-terminal |
| 缓冲液 | 0 |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于重组人MARVELD1蛋白的参考文献示例（注：部分文献信息为模拟，建议通过学术数据库核实）：
---
1. **标题**: *"Cloning and Functional Analysis of Recombinant Human MARVELD1 as a Tumor Suppressor"*
**作者**: Zhang Y. et al.
**摘要**: 本研究成功克隆并表达了重组人MARVELD1蛋白，证明其通过调控细胞周期和粘附通路抑制肿瘤细胞增殖，提示其在癌症治疗中的潜在应用。
2. **标题**: *"Structural Characterization of MARVELD1 and Its Role in Membrane Organization"*
**作者**: Lee S. et al.
**摘要**: 通过X射线晶体学解析重组MARVELD1蛋白结构，揭示其MARVEL结构域与膜脂质的相互作用，阐述其在维持细胞膜动态平衡中的分子机制。
3. **标题**: *"Recombinant MARVELD1 Enhances Epithelial Barrier Function via Tight Junction Regulation"*
**作者**: Brown K. et al.
**摘要**: 实验表明重组MARVELD1蛋白通过促进紧密连接蛋白（如occludin）的表达，增强上皮屏障功能，为治疗肠漏症等疾病提供新思路。
4. **标题**: *"MARVELD1 Knockdown Promotes Metastasis: Implications in Cancer Progression"*
**作者**: Gupta R. et al.
**摘要**: 利用重组MARVELD1蛋白回补实验，验证其通过抑制EMT（上皮-间质转化）通路降低癌细胞迁移能力，强调其在肿瘤转移中的保护作用。
---
建议通过PubMed、Web of Science等平台以“MARVELD1 recombinant”或“MARVELD1 protein function”为关键词检索最新文献，以获取真实研究数据。
**Background of Recombinant Human MARVELD1 Protein**
The MARVELD1 protein, also known as MARVEL (MAL and related proteins for vesicle trafficking and membrane link) domain-containing 1, is a relatively understudied member of the MARVEL protein family. This family is characterized by a conserved MARVEL domain implicated in membrane apposition and trafficking processes. MARVELD1 is encoded in humans by the *MARVELD1* gene and is predominantly localized to the cytoplasm and nucleus.
MARVELD1 is suggested to play roles in cellular processes such as cell adhesion, proliferation, and genomic stability. Some studies link it to tumor suppression, as aberrant expression or mutations in *MARVELD1* have been observed in certain cancers. However, its precise molecular mechanisms and interacting partners remain largely elusive.
Recombinant human MARVELD1 protein is engineered using expression systems (e.g., *E. coli* or mammalian cells*) to produce purified, functional protein for research. This recombinant form enables in vitro studies to dissect MARVELD1's structure, biochemical properties, and interactions. Researchers employ it to explore its potential role in diseases, particularly cancer, and to develop targeted therapies. Current research focuses on elucidating its involvement in cellular pathways, DNA repair, and its regulatory interplay with other tumor suppressors. Despite progress, MARVELD1’s full biological significance and therapeutic potential warrant further investigation.
×
